Published in J Rheumatol on July 01, 2011
Analysis and performance of various classification criteria sets in a Colombian cohort of patients with spondyloarthritis. Clin Rheumatol (2016) 1.07
Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis. Health Qual Life Outcomes (2014) 0.81
Clinimetric properties of the ASAS health index in a cohort of Italian patients with axial spondyloarthritis. Health Qual Life Outcomes (2016) 0.79
ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondyloarthritis. Rheumatology (Oxford) (2015) 0.77
Higher Levels of Secretory IgA Are Associated with Low Disease Activity Index in Patients with Reactive Arthritis and Undifferentiated Spondyloarthritis. Front Immunol (2017) 0.75
Clinical utility of the ASDAS index in comparison with BASDAI in patients with ankylosing spondylitis (Axis Study). Rheumatol Int (2017) 0.75
The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis. Arthritis Rheum (2004) 2.99
The concept of axial spondyloarthritis: joint statement of the spondyloarthritis research and treatment network and the Assessment of SpondyloArthritis international Society in response to the US Food and Drug Administration's comments and concerns. Arthritis Rheumatol (2014) 2.14
What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter. Arthritis Rheum (2004) 2.13
EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis (2013) 2.05
The benefits of early treatment in rheumatoid arthritis: confounding by indication, and the issue of timing. Arthritis Rheum (2003) 1.84
Minimal disease activity for rheumatoid arthritis: a preliminary definition. J Rheumatol (2005) 1.70
Non-steroidal anti-inflammatory drugs for acute gout. Cochrane Database Syst Rev (2014) 1.60
The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis. Ann Rheum Dis (2010) 1.39
Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative. Ann Rheum Dis (2013) 1.39
Smoking and overweight determine the likelihood of developing rheumatoid arthritis. Ann Rheum Dis (2012) 1.30
Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis. Arthritis Rheum (2009) 1.24
International spondyloarthritis interobserver reliability exercise--the INSPIRE study: II. Assessment of peripheral joints, enthesitis, and dactylitis. J Rheumatol (2007) 1.11
Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis. Ann Rheum Dis (2010) 1.10
IBD and arthropathies: a practical approach to its diagnosis and management. Gut (2011) 1.06
International spondyloarthritis interobserver reliability exercise--the INSPIRE study: I. Assessment of spinal measures. J Rheumatol (2007) 1.04
MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor. Ann Rheum Dis (2012) 1.00
Repair of joint erosions in rheumatoid arthritis: prevalence and patient characteristics in a large inception cohort. Ann Rheum Dis (2009) 0.98
Radiographic severity of rheumatoid arthritis in African Americans: results from a multicenter observational study. Arthritis Care Res (Hoboken) (2010) 0.98
EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteria. Ann Rheum Dis (2013) 0.97
The joint-gut axis in inflammatory bowel diseases. J Crohns Colitis (2009) 0.97
How well are the ASAS/OMERACT Core Outcome Sets for Ankylosing Spondylitis implemented in randomized clinical trials? A systematic literature review. Clin Rheumatol (2014) 0.95
Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis). Cochrane Database Syst Rev (2015) 0.94
Magnetic resonance imaging of inflammatory lesions in the spine in ankylosing spondylitis clinical trials: is paramagnetic contrast medium necessary? J Rheumatol (2005) 0.92
Safety of nonsteroidal antiinflammatory drugs and/or paracetamol in people receiving methotrexate for inflammatory arthritis: a Cochrane systematic review. J Rheumatol Suppl (2012) 0.91
The value of magnetic resonance imaging and ultrasound in undifferentiated arthritis: a systematic review. J Rheumatol Suppl (2011) 0.89
Assessment of global disease activity in RA patients monitored in the METEOR database: the patient's versus the rheumatologist's opinion. Clin Rheumatol (2013) 0.89
Association of joint space narrowing with impairment of physical function and work ability in patients with early rheumatoid arthritis: protection beyond disease control by adalimumab plus methotrexate. Ann Rheum Dis (2012) 0.89
Measuring pain and efficacy of pain treatment in inflammatory arthritis: a systematic literature review. J Rheumatol Suppl (2012) 0.88
Application of the 2010 ACR/EULAR classification criteria in patients with very early inflammatory arthritis: analysis of sensitivity, specificity and predictive values in the SAVE study cohort. Ann Rheum Dis (2012) 0.87
Epistasis between two HLA antigens defines a subset of individuals at a very high risk for ankylosing spondylitis. Ann Rheum Dis (2012) 0.86
Pain management for inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and other spondylarthritis) and gastrointestinal or liver comorbidity. Cochrane Database Syst Rev (2012) 0.85
Report from the OMERACT Hand Osteoarthritis Special Interest Group: advances and future research priorities. J Rheumatol (2014) 0.84
The value of conventional radiographs in undifferentiated arthritis: a systematic review. J Rheumatol Suppl (2011) 0.84
Methotrexate treatment and mortality in rheumatoid arthritis. Lancet (2002) 0.84
Application of the OMERACT filter to scoring methods for magnetic resonance imaging of the sacroiliac joints and the spine. Recommendations for a research agenda at OMERACT 7. J Rheumatol (2005) 0.83
Association of IL4R single-nucleotide polymorphisms with rheumatoid nodules in African Americans with rheumatoid arthritis. Arthritis Res Ther (2010) 0.83
The prognostic value of baseline erosions in undifferentiated arthritis. Arthritis Res Ther (2009) 0.83
FCRL3 -169C/C genotype is associated with anti-citrullinated protein antibody-positive rheumatoid arthritis and with radiographic progression. J Rheumatol (2011) 0.83
The role of corticosteroids for pain relief in persistent pain of inflammatory arthritis: a systematic literature review. J Rheumatol Suppl (2012) 0.82
Paracetamol for the management of pain in inflammatory arthritis: a systematic literature review. J Rheumatol Suppl (2012) 0.82
Generalized bone loss as a predictor of three-year radiographic damage in African American patients with recent-onset rheumatoid arthritis. Arthritis Rheum (2010) 0.81
Should anti-citrullinated protein antibody and rheumatoid factor status be reassessed during the first year of followup in recent-onset arthritis? A longitudinal study. J Rheumatol (2011) 0.81
Early aggressive therapy in rheumatoid arthritis: a 'window of opportunity'? Nat Clin Pract Rheumatol (2005) 0.80
Diagnostic and predictive value of acute-phase reactants in adult undifferentiated peripheral inflammatory arthritis: a systematic review. J Rheumatol Suppl (2011) 0.80
OMERACT magnetic resonance imaging initiative on structural and inflammatory lesions in ankylosing spondylitis--report of a special interest group at OMERACT 10 on sacroiliac joint and spine lesions. J Rheumatol (2011) 0.80
Combination therapy for pain management in inflammatory arthritis: a Cochrane systematic review. J Rheumatol Suppl (2012) 0.80
Increase in bone density in patients with spondyloarthritis during anti-tumor necrosis factor therapy: 6-year followup study. J Rheumatol (2013) 0.80
Comorbidities in patients with spondyloarthritis. Rheum Dis Clin North Am (2012) 0.80
Methotrexate saves lives: a pearl of observational research. Arthritis Rheum (2013) 0.79
Updating the OMERACT filter: core areas as a basis for defining core outcome sets. J Rheumatol (2014) 0.79
Magnetic resonance imaging in the diagnosis of ankylosing spondylitis: be aware of gold standards and circularity. J Rheumatol (2010) 0.79
Justification for including MRI as a tool in the diagnosis of axial SpA. Nat Rev Rheumatol (2010) 0.78
Updating the OMERACT filter: implications of filter 2.0 to select outcome instruments through assessment of "truth": content, face, and construct validity. J Rheumatol (2014) 0.78
The efficacy and safety of antidepressants in inflammatory arthritis: a Cochrane systematic review. J Rheumatol Suppl (2012) 0.78
Safety of pain therapy during pregnancy and lactation in patients with inflammatory arthritis: a systematic literature review. J Rheumatol Suppl (2012) 0.78
Diagnostic and prognostic value of synovial biopsy in adult undifferentiated peripheral inflammatory arthritis: a systematic review. J Rheumatol Suppl (2011) 0.78
The efficacy and safety of muscle relaxants in inflammatory arthritis: a Cochrane systematic review. J Rheumatol Suppl (2012) 0.78
Updating the OMERACT filter: discrimination and feasibility. J Rheumatol (2014) 0.78
Adenosine 5'-triphosphate infusions reduced disease activity and inflammation in a patient with active rheumatoid arthritis. Rheumatology (Oxford) (2010) 0.77
Brief report: erosions and sclerosis on radiographs precede the subsequent development of syndesmophytes at the same site: a twelve-year prospective followup of patients with ankylosing spondylitis. Arthritis Rheumatol (2014) 0.77
The efficacy and safety of opioids in inflammatory arthritis: a Cochrane systematic review. J Rheumatol Suppl (2012) 0.77
Pain pharmacotherapy in patients with inflammatory arthritis and concurrent cardiovascular or renal disease: a Cochrane systematic review. J Rheumatol Suppl (2012) 0.77
Validity of the disease activity score in undifferentiated arthritis. Arthritis Care Res (Hoboken) (2010) 0.76
Development and validation of the French ASQoL questionnaire. Clin Exp Rheumatol (2010) 0.76
Tools for monitoring spondyloarthritis in clinical practice. Nat Rev Rheumatol (2009) 0.75
Dramatic repair of joint damage in psoriatic arthritis. J Rheumatol (2011) 0.75
How do gastrointestinal or liver comorbidities influence the choice of pain treatment in inflammatory arthritis? A Cochrane systematic review. J Rheumatol Suppl (2012) 0.75
[The multidisciplinary practice guideline "The responsible use of biologicals"]. Ned Tijdschr Geneeskd (2011) 0.75
Cardiovascular Morbidity and Mortality Among Working Individuals With Rheumatic Disease: Results From a Large Prospective Cohort Study. J Clin Rheumatol (2015) 0.75
How to investigate and follow up undifferentiated peripheral inflammatory arthritis? 3e initiative 2008-2009: systematic reviews and clinical algorithm. J Rheumatol Suppl (2011) 0.75
Intra articular injection with corticosteroids in patients with recent onset rheumatoid arthritis: subanalyses from the BeSt study. Clin Rheumatol (2014) 0.75
Effects of cardiovascular comorbidities on work participation in rheumatic diseases: a prospective cohort study among working individuals. Arthritis Care Res (Hoboken) (2014) 0.75
Concomitant therapies as an outcome measure. Part 1: Drugs. J Rheumatol (2005) 0.75
Efficacy and safety of neuromodulators in inflammatory arthritis: a Cochrane systematic review. J Rheumatol Suppl (2012) 0.75
Algorithm for identification of undifferentiated peripheral inflammatory arthritis: a multinational collaboration through the 3e initiative. J Rheumatol Suppl (2011) 0.75